Oncolytics Biotech (ONCY) Earnings Date, Estimates & Call Transcripts $0.59 +0.02 (+3.84%) Closing price 04/29/2025 03:59 PM EasternExtended Trading$0.59 +0.00 (+0.35%) As of 04/29/2025 05:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Oncolytics Biotech Earnings Summary Upcoming Q3 Earnings DateMay. 8Before Market OpensEstimatedConsensus EPS (Aug. 1) -$0.08 Actual EPS (Aug. 1) -$0.07 Beat By $0.01 Oncolytics Biotech issued Q2 2024 earnings on August 1, 2024, reporting an EPS of -$0.07, which topped analysts' consensus estimates of -$0.08 by $0.01. With a trailing EPS of -$0.30, Oncolytics Biotech's earnings are expected to decrease next year, from ($0.28) to ($0.30) per share. Q2 2024 Earnings ResourcesQ2 2024 Earnings ReportConference Call Transcript & Audio Press Release (8-K)ONCY Upcoming EarningsOncolytics Biotech's Q1 2025 earnings is scheduled for Thursday, May 8, 2025, with a conference call scheduled at 4:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q1 2025 Earnings ReportPowered by Get Oncolytics Biotech Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Oncolytics Biotech and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataONCY Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Oncolytics Biotech Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.09-$0.08-$0.09Q2 20251-$0.07-$0.07-$0.07Q3 20251-$0.07-$0.07-$0.07Q4 20251-$0.06-$0.06-$0.06FY 20255($0.29)($0.28)($0.29) Oncolytics Biotech Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/8/2025(Estimated)-------8/1/2024Q2 2024-$0.08-$0.07+$0.01-$0.07--5/9/2024Q1 2024-$0.09-$0.07+$0.02-$0.07--3/7/2024Q4 2023-$0.11-$0.04+$0.07-$0.04--11/3/2023Q3 2023-$0.07-$0.10 -$0.03-$0.10--8/14/2023Q2 2023-$0.09-$0.09--$0.09--5/5/2023Q1 2023-$0.07-$0.07--$0.07-- Oncolytics Biotech Earnings - Frequently Asked Questions When is Oncolytics Biotech's earnings date? Oncolytics Biotech has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 8th, 2025 based off last year's report dates. Learn more on ONCY's earnings history. Did Oncolytics Biotech beat their earnings estimates last quarter? In the previous quarter, Oncolytics Biotech (NASDAQ:ONCY) reported ($0.07) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.08) by $0.01. Learn more on analysts' earnings estimate vs. ONCY's actual earnings. How can I listen to Oncolytics Biotech's earnings conference call? The conference call for Oncolytics Biotech's latest earnings report can be listened to online. Listen to Conference Call How can I read Oncolytics Biotech's conference call transcript? The conference call transcript for Oncolytics Biotech's latest earnings report can be read online. Read Transcript How much profit does Oncolytics Biotech generate each year? Oncolytics Biotech (NASDAQ:ONCY) has a recorded net income of -$20.56 million. ONCY has generated -$0.30 earnings per share over the last four quarters. What is Oncolytics Biotech's EPS forecast for next year? Oncolytics Biotech's earnings are expected to decrease from ($0.28) per share to ($0.30) per share in the next year. More Earnings Resources from MarketBeat Related Companies Eledon Pharmaceuticals Earnings Results Cardiff Oncology Earnings Results Voyager Therapeutics Earnings Results Alumis Earnings Results Fulcrum Therapeutics Earnings Results Y-mAbs Therapeutics Earnings Results biote Earnings Results INmune Bio Earnings Results Esperion Therapeutics Earnings Results Inhibrx Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alphabet Rebounds After Strong Earnings and Buyback AnnouncementMarkets Think Robinhood Earnings Could Send the Stock UpIs the Floor in for Lam Research After Bullish Earnings?Texas Instruments: Earnings Beat, Upbeat Guidance Fuel RecoveryMarket Anticipation Builds: Joby Stock Climbs Ahead of EarningsIs Intuitive Surgical a Buy After Volatile Reaction to Earnings?Seismic Shift at Intel: Massive Layoffs Precede Crucial Earnings This page (NASDAQ:ONCY) was last updated on 4/30/2025 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredThe Silent Heist Draining Your Retirement SavingsU.S. Debt Crisis - A Silent Heist of Your Retirement Savings Americans are losing wealth daily and don't ev...American Hartford Gold | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oncolytics Biotech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncolytics Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ONCY Stock Free ONCY Stock Alerts